# C4 Adversary Tournament Execution Report: Barrier 2 Synthesis

> adv-executor | Iteration 1 | C4 Tournament | PROJ-014 | 2026-02-28
> Target: barrier-2/synthesis.md (TASK-007, ps-synthesizer)
> Criticality: C4 (Critical) — all 10 strategies required
> Templates: S-010, S-003, S-002, S-004, S-001, S-007, S-011, S-012, S-013, S-014

---

## Document Sections

| Section | Purpose |
|---------|---------|
| [Execution Context](#execution-context) | Tournament metadata |
| [S-010: Self-Refine](#s-010-self-refine) | Self-review findings |
| [S-003: Steelman Technique](#s-003-steelman-technique) | Strongest-case reconstruction |
| [S-002: Devil's Advocate](#s-002-devils-advocate) | Counter-argument construction |
| [S-004: Pre-Mortem Analysis](#s-004-pre-mortem-analysis) | Prospective failure enumeration |
| [S-001: Red Team Analysis](#s-001-red-team-analysis) | Adversarial threat vector analysis |
| [S-007: Constitutional AI Critique](#s-007-constitutional-ai-critique) | HARD rule compliance check |
| [S-011: Chain-of-Verification](#s-011-chain-of-verification) | Factual claim verification |
| [S-012: FMEA](#s-012-fmea) | Failure mode and effects analysis |
| [S-013: Inversion Technique](#s-013-inversion-technique) | Assumption inversion and stress-test |
| [S-014: LLM-as-Judge](#s-014-llm-as-judge) | Final quality scoring |
| [Tournament Summary](#tournament-summary) | Aggregated findings and verdict |

---

## Execution Context

| Attribute | Value |
|-----------|-------|
| **Strategy Set** | S-010, S-003, S-002, S-004, S-001, S-007, S-011, S-012, S-013, S-014 |
| **Template Base** | `.context/templates/adversarial/` |
| **Deliverable** | `barrier-2/synthesis.md` (TASK-007, ps-synthesizer) |
| **Deliverable Version** | 1.0.0 |
| **Criticality** | C4 (Critical) |
| **Quality Gate** | >= 0.95 (C4 per orchestration directive) |
| **Executed** | 2026-02-28 |
| **Iteration** | I1 |
| **H-16 Check** | S-003 precedes S-002 — COMPLIANT |

---

## S-010: Self-Refine

> **Finding Prefix:** SR | **Template:** s-010-self-refine.md | **Protocol:** 6-step self-review

### Objectivity Assessment

Reviewer adopts external evaluator stance on TASK-007 synthesis. Attachment level: LOW (analysis produced by separate ps-synthesizer agent; reviewing as independent adv-executor). Proceeding with standard scrutiny.

### Findings Summary

| ID | Severity | Finding | Section |
|----|----------|---------|---------|
| SR-001-i1 | Major | "MEDIUM-HIGH" vs. "MEDIUM" terminological divergence resolved but not fully reconciled in synthesis narrative | ST-2 |
| SR-002-i1 | Major | Assumption U-004 (Anthropic specificity dominance) not quantified — "not dominated" is asserted without threshold | ST-3 |
| SR-003-i1 | Minor | Self-review checklist passes all items but does not cite which synthesis iteration addressed each item | Self-Review Checklist |
| SR-004-i1 | Minor | ST-7 sufficiency verdict lacks explicit mapping to the four named prerequisites — "SUFFICIENT, subject to four prerequisites" is stated but prerequisites are listed without a formal sufficiency gap analysis | ST-7 |
| SR-005-i1 | Minor | L0 Executive Summary is a single dense paragraph (~400 words) violating progressive disclosure principles — key verdict buried in prose | L0 |

### Detailed Findings

**SR-001-i1: Terminological divergence insufficiently resolved**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | ST-2: Confidence Reconciliation |
| **Strategy Step** | Step 2: Systematic Self-Critique — Internal Consistency check |

**Evidence:** ST-2 states: "TASK-005 labels E-FOR-B-002 (Barreto & Jana) as 'MEDIUM-HIGH' while TASK-006 labels the same finding as 'MEDIUM' after its I5 upgrade. This is NOT a substantive contradiction." The synthesis resolves this as "minor terminological variation" but then selects "MEDIUM (scoped: negation accuracy)" as the combined label in the Confidence Reconciliation Matrix (L2). No explicit justification is provided for why the combined label aligns with TASK-006's "MEDIUM" rather than TASK-005's "MEDIUM-HIGH" or a synthesis label such as "MEDIUM (upper band)."

**Analysis:** A downstream consumer reading only L2's confidence matrix will see "MEDIUM" and may not trace to the resolution rationale in ST-2. The synthesis adopts one deliverable's label without explaining the selection criterion.

**Recommendation:** Add a one-sentence rationale in the L2 Confidence Reconciliation Matrix row for A-23: "Combined label aligns with TASK-006 post-I5 calibration because the I5 upgrade represents the most recent confidence assessment and the operationalized scale defines MEDIUM as exactly 1 T1 study with no replication."

---

**SR-002-i1: Assumption U-004 quantification missing**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | ST-3: Cross-Document Consistency Check |
| **Strategy Step** | Step 2: Systematic Self-Critique — Evidence Quality check |

**Evidence:** Assumption U-004 states: "The VS-001 evidence is exclusively Anthropic (Claude Code behavioral rules). The supplemental evidence report extends this to OpenAI (C-6, C-7) and LlamaIndex (C-11). TASK-006 D5 treats this as three-vendor convergence. Downstream phases must not over-weight Anthropic-specific evidence when making general claims."

The assumption is correctly named but provides no quantitative basis for the "three-vendor convergence" claim. The L2 cross-reference matrix shows VS-001–VS-004 with 33 instances. It does not break down how many instances are Anthropic-only vs. multi-vendor. If 30 of 33 instances are Anthropic, the "three-vendor convergence" framing is misleading; if they are evenly distributed, the claim is robust.

**Analysis:** This is an evidence quality gap. The synthesis warns downstream consumers not to over-weight Anthropic specificity but does not quantify the Anthropic concentration in the 33-instance catalog.

**Recommendation:** Add to U-004 or to the ST-5 Phase 4 inputs table: the supplemental-vendor-evidence.md vendor distribution (e.g., "X of 33 instances are Anthropic/Claude Code; Y are OpenAI; Z are LlamaIndex") so downstream consumers have the basis to apply the caveat.

---

### Scoring Impact

| Dimension | Weight | Impact | Rationale |
|-----------|--------|--------|-----------|
| Completeness | 0.20 | Neutral-Positive | All seven synthesis tasks addressed; all four inputs integrated |
| Internal Consistency | 0.20 | Slight-Negative | SR-001 represents an unresolved label selection gap |
| Methodological Rigor | 0.20 | Neutral | Braun & Clarke methodology applied; steps documented |
| Evidence Quality | 0.15 | Slight-Negative | SR-002: quantification absent for Anthropic concentration |
| Actionability | 0.15 | Positive | PG-001–PG-005 and downstream NEVER constraints are specific |
| Traceability | 0.10 | Positive | All claims cite specific source document and section identifiers |

### Decision

**Outcome:** Ready for external adversarial critique (S-003 onward).
**Rationale:** No Critical findings; two Major findings are resolvable with targeted additions. Sufficient quality for tournament progression.
**Next Action:** Apply S-003 Steelman.

---

## S-003: Steelman Technique

> **Finding Prefix:** SM | **Template:** s-003-steelman.md | **Protocol:** 6-step constructive strengthening

### Step 1: Charitable Interpretation

**Core thesis:** Barrier 2 synthesis correctly integrates four high-quality inputs and produces a coherent Phase 2 position: the 60% hallucination reduction hypothesis is alive as a research question with a null finding on controlled evidence, the evidence base is structured into three confidence tiers, the experimental foundation is sufficient, and downstream phases have operationalized inputs with explicit NEVER constraints.

**Key claims identified:**
1. The two Phase 2 deliverables are internally consistent with only terminological variation
2. The confidence reconciliation produces three distinct tiers (HIGH/MEDIUM/UNTESTED)
3. The synthesis is "SUFFICIENT" for Phase 2 completion subject to four prerequisites
4. Downstream phase constraints are operationalized as NEVER statements
5. Researcher circularity risk is fully disclosed
6. Vendor evidence (supplemental) is fully integrated

**Assessment:** Fundamentally coherent. Strong thesis. Proceeds to strengthening.

### Steelman Reconstruction — Improvement Findings

| ID | Severity | Original | Strengthened | Dimension |
|----|----------|----------|-------------|-----------|
| SM-001-i1 | Major | L0 summary buries the most actionable finding (PG-001–PG-005 are unconditional) in the middle of a dense paragraph | L0 should open with the highest-confidence actionable finding, then explain why the directional verdict is withheld | Actionability |
| SM-002-i1 | Major | ST-4 "combined directional picture" section does not explicitly articulate the epistemic floor — what CAN be stated with HIGH confidence | Add an explicit "Established findings (HIGH confidence)" sub-section in ST-4 that lists findings that can be used NOW without Phase 2 | Completeness |
| SM-003-i1 | Minor | Assumption U-003 (context compaction) is buried in ST-3 but T-004 is a prominent risk; the synthesis does not cross-link U-003 to ST-5 Phase 5 deployment constraints | Cross-link U-003 explicitly into the Phase 5 inputs table as a deployment constraint | Traceability |
| SM-004-i1 | Minor | The "NEVER conflate" imperatives are embedded in narrative text but not consistently anchored to a specific section identifier | Create a "Key Imperatives Index" in L0 or L2 that consolidates all NEVER/MUST constraints for quick reference by downstream consumers | Actionability |

### Best Case Scenario

**Conditions under which this synthesis is most compelling:**
- A downstream consumer reads ST-4 and correctly understands that PG-001–PG-005 are evidence-grounded NOW while the directional verdict awaits Phase 2 experimental data
- The three-tier confidence structure (HIGH/MEDIUM/UNTESTED) is used as the governing lens by Phase 3 taxonomy work
- Phase 5 treats the n=30 pilot design as non-negotiable before full-experiment launch

**Confidence at steelman maximum:** 0.91-0.93 as-is; potentially 0.95+ with SR-001, SR-002, SM-001, SM-002 addressed

### Scoring Impact (S-003)

| Dimension | Weight | Steelman Assessment |
|-----------|--------|---------------------|
| Completeness | 0.20 | Strong; ST-7 sufficiency assessment is thorough; SM-002 identifies one structural gap |
| Internal Consistency | 0.20 | Strong; unanimous agreement across all four inputs is demonstrated |
| Methodological Rigor | 0.20 | Strong; Braun & Clarke methodology applied; cross-reference matrix present |
| Evidence Quality | 0.15 | Strong; T1/T4 distinctions maintained throughout; scope caveats correct |
| Actionability | 0.15 | Good; PG-001–PG-005 operationalized; SM-001 identifies presentation gap |
| Traceability | 0.10 | Good; all claims cite specific identifiers; SM-003 identifies one cross-link gap |

---

## S-002: Devil's Advocate

> **Finding Prefix:** DA | **Template:** s-002-devils-advocate.md | **Protocol:** 5-step counter-argument construction
> **H-16 Check:** S-003 completed — COMPLIANT

### Role Assumption

Adopting adversarial role: argue that the synthesis overstates its own rigor, under-identifies risks, and creates false confidence about Phase 2 readiness. Deliverable: barrier-2/synthesis.md. Criticality: C4.

### Assumption Inventory

| Assumption | Type | Challenge |
|------------|------|-----------|
| A-1: The four input documents are authoritative and internally sufficient | Explicit | What if key evidence was missed in Phase 1 that changes the confidence picture? |
| A-2: "Terminological variation" between TASK-005 and TASK-006 is not substantive | Explicit | What if "MEDIUM-HIGH" vs. "MEDIUM" represents genuine epistemic disagreement disguised as label choice? |
| A-3: Three-vendor convergence is meaningful for generalizability | Explicit | Vendor convergence on a design choice does not imply it is optimal — selection bias may explain the pattern |
| A-4: The synthesis has no downstream consumer who would misread it | Implicit | The NEVER constraints are protective but their compliance depends on the downstream phase implementing them faithfully |
| A-5: The 12-level hierarchy's internal ordering is stable | Implicit | The hierarchy was produced by a single narrative synthesis; no independent validation exists for inter-level ordering within ranks 9–11 |
| A-6: The experimental design is executable as specified | Implicit | Prerequisites P-001 through P-004 may block execution; the synthesis does not assign ownership for prerequisite completion |

### Counter-Arguments

**DA-001-i1: The synthesis manufactures consensus where genuine ambiguity exists**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | ST-2, ST-3 |
| **Affected Dimension** | Internal Consistency |

**Counter-argument:** The synthesis repeatedly asserts that the two deliverables are "aligned" and that their differences are "terminological, not epistemic." However, TASK-005 was produced by a claim-validation methodology and TASK-006 by a comparative-effectiveness methodology. These are structurally different analytical lenses. The synthesis does not examine whether the claim-validation lens might have missed dimensions that the effectiveness lens captures, or vice versa. Declaring "no material contradictions" on the basis of identical conclusions papers over the possibility that both deliverables share the same blind spots — they drew from overlapping evidence bases and applied similar confidence scales. The real test of alignment would be independent replication by a third analyst using different methods, not cross-reference within the same researcher's pipeline.

**Evidence from deliverable:** ST-3 states "No material contradictions were identified." The synthesis acknowledges "researcher circularity risk" (Assumption U-004 context) but treats it as a disclosure rather than a structural limitation of the alignment claim itself.

**Implication:** The "UNANIMOUS" agreement labels in the L2 cross-reference matrix may create false confidence. A downstream consumer could cite this synthesis as evidence of convergent validity when the convergence is methodologically constructed.

---

**DA-002-i1: The "SUFFICIENT" readiness verdict under-weights execution risk**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | ST-7 |
| **Affected Dimension** | Methodological Rigor |

**Counter-argument:** The synthesis concludes "SUFFICIENT, subject to four named prerequisites." This framing inverts the actual risk profile. Prerequisites P-002 (pre-validated example pair pool with kappa ≥ 0.80) and P-003 (evaluator recruitment and training) are non-trivial resource requirements that the synthesis treats as minor administrative items. The equivalence validation protocol requires constructing 10 pre-validated pairs across 5 task categories — this is novel methodology research, not data collection. If P-002 cannot be satisfied (pairs fail to achieve kappa ≥ 0.80), the entire pilot design collapses. The synthesis does not assign any owner for these prerequisites, does not estimate the time required, and does not define what "INSUFFICIENT" would look like if prerequisites fail.

**Evidence from deliverable:** ST-7 states the pilot design is "SUFFICIENT, subject to four named prerequisites" but the prerequisites table provides only "What is needed" and "Source" — no effort estimate, no owner, no fallback if a prerequisite is not achievable.

**Implication:** Downstream Phase 5 may treat Phase 2 as fully ready and discover prerequisite failures late in implementation, wasting execution effort.

---

**DA-003-i1: The null finding protection may inadvertently anchor the Phase 2 experiment toward a negative result**

| Attribute | Value |
|-----------|-------|
| **Severity** | Minor |
| **Section** | ST-4, Self-Review Checklist |
| **Affected Dimension** | Evidence Quality |

**Counter-argument:** The synthesis's repeated emphasis on null finding protection ("NEVER cite as established or disproven," "research question not a finding") may create a framing bias where Phase 2 experimenters are primed to expect a null or inconclusive result. The PG-003 contingency planning for an inconclusive scenario — which the synthesis explicitly strengthens — may function as a rationalization mechanism that makes inconclusive results more acceptable than they should be. Science requires equipoise; a synthesis that devotes more structural space to inconclusive-outcome planning than to positive-outcome integration may implicitly signal which result is expected.

**Evidence from deliverable:** The self-review checklist item "Absence of published evidence not treated as evidence of absence" is checked as PASS, but ST-4 and ST-7 together devote substantial space to the inconclusive scenario (PG-003 contingency, π_d sensitivity table caveat) while the positive-outcome scenario is not similarly elaborated.

---

**DA-004-i1: Downstream constraints (NEVER statements) lack enforcement mechanism**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | ST-5 |
| **Affected Dimension** | Actionability |

**Counter-argument:** The synthesis produces extensive "NEVER" constraints for downstream phases (ST-5, ST-7, downstream specification tables). These are well-reasoned but have no enforcement mechanism. A downstream Phase 3 or Phase 4 document author who does not read this synthesis carefully will not encounter these constraints automatically. The constraints rely entirely on voluntary compliance by future document authors. There is no cross-reference mechanism, no checklist embedded in Phase 3/4/5 templates, and no adversary gate that specifically verifies downstream phase compliance with Barrier 2 synthesis constraints.

**Evidence from deliverable:** ST-5 Phase 3 inputs table lists three downstream constraints (NEVER statements) but no pointer to how Phase 3 will be verified against them. The synthesis does not recommend that its NEVER constraints be embedded as HARD rules in Phase 3/4/5 orchestration gates.

---

### Scoring Impact (S-002)

| Dimension | Weight | Impact | Rationale |
|-----------|--------|--------|-----------|
| Completeness | 0.20 | Neutral | All sections present; DA-004 identifies missing enforcement mechanism |
| Internal Consistency | 0.20 | Slight-Negative | DA-001 identifies constructed consensus risk |
| Methodological Rigor | 0.20 | Negative | DA-002 identifies under-weighted execution risk in readiness verdict |
| Evidence Quality | 0.15 | Slight-Negative | DA-003 identifies potential framing bias in null-finding emphasis |
| Actionability | 0.15 | Negative | DA-004 identifies NEVER constraints without enforcement mechanisms |
| Traceability | 0.10 | Neutral | Traceability is strong; no DA findings target this dimension |

---

## S-004: Pre-Mortem Analysis

> **Finding Prefix:** PM | **Template:** s-004-pre-mortem.md | **Protocol:** Prospective hindsight — "it has already failed"

### Failure Declaration

"It is 6 months after the Barrier 2 synthesis was approved. The PROJ-014 research has failed. Downstream phases used the synthesis in ways that contradicted its stated constraints. The experimental design was not executed as specified. The research conclusions were misrepresented in Jerry Framework documentation. How did this happen?"

### Failure Mode Enumeration

**PM-001-i1: The "three confidence tiers" were collapsed into a binary by downstream consumers**

| Attribute | Value |
|-----------|-------|
| **Severity** | Critical |
| **Section** | ST-2, ST-4 |
| **Affected Dimension** | Internal Consistency / Actionability |

**Failure narrative:** Downstream Phase 4 (Jerry Framework Application) authors read the synthesis and extracted the two most memorable labels: "HIGH confidence" (vendor self-practice) and "UNTESTED" (hallucination reduction claim). The MEDIUM-confidence findings for ranks 5–6 techniques were either elevated to HIGH or merged with UNTESTED. The synthesis's carefully constructed three-tier structure collapsed into a binary: "what we know" vs. "what we don't know." PG-001 through PG-005 were all treated as equally authoritative regardless of their underlying confidence tier.

**Root cause in synthesis:** The three-tier structure is clearly presented in ST-2 but is NOT repeated in ST-4's practitioner implications. PG-001 through PG-005 are presented without their confidence tier tags in the "Practitioner implications" section, making them appear uniformly authoritative.

**Evidence:** ST-4 states: "PG-001 through PG-005 constitute the evidence-based practitioner position. These are unconditional in the following sense: they are grounded in T1 and T4 evidence that does not require Phase 2 resolution." This "unconditional" framing applies to all five guidelines identically, even though PG-003 (pair enforcement-tier constraints with consequences) is specifically noted as "Working practice (T4 observational)" in the Phase 4 table — a different confidence level than PG-001 (T1+T3, unconditional).

---

**PM-002-i1: The pilot was launched without completing prerequisite P-002, producing invalid results**

| Attribute | Value |
|-----------|-------|
| **Severity** | Critical |
| **Section** | ST-7 |
| **Affected Dimension** | Completeness / Methodological Rigor |

**Failure narrative:** Phase 5 received the synthesis's "SUFFICIENT" verdict and launched the pilot before achieving kappa ≥ 0.80 on the equivalence validation protocol. The pre-validated pair pool achieved only kappa = 0.62 across pairs, but the pilot proceeded because the synthesis's NEVER constraint ("NEVER launch the full experiment before the pilot") was interpreted as only restricting the full experiment, not requiring prerequisite completion before the pilot. The pilot's P-002 NEVER constraint is only stated in ST-5 Phase 5 table but the ST-7 sufficiency verdict does not reiterate that prerequisites are BLOCKING conditions.

**Root cause in synthesis:** The "SUFFICIENT, subject to four named prerequisites" framing logically permits proceeding if prerequisites are treated as parallel work rather than blocking gates. The synthesis does not explicitly state that the prerequisites are BLOCKING (i.e., pilot cannot launch until all four are satisfied).

**Evidence:** ST-7 prerequisite table uses "What is needed" framing, not "BLOCKING gate: pilot MUST NOT launch until this is satisfied."

---

**PM-003-i1: The retrospective A/B comparison was cited as directional evidence by a downstream author**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | ST-6 |
| **Affected Dimension** | Evidence Quality |

**Failure narrative:** A Phase 4 author cited ST-6's retrospective comparison table (PROJ-014 vs. PROJ-007 quality gate results) as "evidence that negative-constraint governance achieves comparable quality outcomes to positive-framing governance." The confound analysis in ST-6 was overlooked; the table with numbers was extracted and reused.

**Root cause in synthesis:** The retrospective comparison table in ST-6 presents numbers (first-pass score, iterations, final score) in a format optimized for scanning, with the confound verdict in narrative text below the table. A reader scanning tables will encounter the numbers first and may not read the confound analysis.

**Evidence:** ST-6 table format presents "Observed direction" column showing "PROJ-007 higher first-pass" etc., which creates a directional appearance despite the analysis explicitly labeling it as confounded.

---

**PM-004-i1: Assumption U-001 (hierarchy stability) was violated in Phase 3 without detection**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | ST-3 |
| **Affected Dimension** | Traceability |

**Failure narrative:** Phase 3 taxonomy work reordered the 12-level effectiveness hierarchy based on additional literature review, producing a 10-level taxonomy. The synthesis's constraint (Assumption U-001: "NEVER treat the 12-level hierarchy as empirically validated; it is a narrative synthesis product") was used as justification for this reordering. However, the reordering disrupted the mapping between TASK-005 pilot conditions (C1–C7) and the hierarchy levels, making the pilot design no longer aligned with the taxonomy.

**Root cause in synthesis:** U-001 correctly warns that the hierarchy is not empirically validated but does not specify that any modification must preserve the C1–C7 pilot condition alignment. The constraint is protective against overclaiming hierarchy validity but inadvertently opens the door to hierarchy modification without experimental impact assessment.

---

**PM-005-i1: Researcher circularity was disclosed but not operationally blocked**

| Attribute | Value |
|-----------|-------|
| **Severity** | Minor |
| **Section** | ST-3 |
| **Affected Dimension** | Methodological Rigor |

**Failure narrative:** The synthesis discloses researcher circularity (Assumption U-004 context, A-002 structural circularity from TASK-006) but does not recommend any operational mitigation. Six months later, the Phase 2 pilot is conducted by the same research team without independent replication. The circularity disclosure became a pro forma acknowledgment rather than an operational constraint.

**Root cause in synthesis:** ST-3 notes circularity as "Resolved: both deliverables explicitly disclose circularity; both require independent replication before VS-002 interpretation relied upon." But ST-5 Phase 4 inputs do not include any operational constraint that maps to independent replication requirement.

---

### Scoring Impact (S-004)

| Dimension | Weight | Impact | Rationale |
|-----------|--------|--------|-----------|
| Completeness | 0.20 | Negative | PM-002 identifies that prerequisite BLOCKING status is not explicit |
| Internal Consistency | 0.20 | Negative | PM-001 identifies that PG-001–PG-005 confidence differentiation is lost in ST-4 |
| Methodological Rigor | 0.20 | Neutral | Methodology is sound; execution risk framing (PM-002) is the gap |
| Evidence Quality | 0.15 | Slight-Negative | PM-003 identifies table-vs-narrative presentation risk |
| Actionability | 0.15 | Negative | PM-001 and PM-004 identify actionability gaps that could cause downstream misuse |
| Traceability | 0.10 | Slight-Negative | PM-004 identifies hierarchy modification risk from lack of pilot alignment constraint |

---

## S-001: Red Team Analysis

> **Finding Prefix:** RT | **Template:** s-001-red-team.md | **Protocol:** Adversarial emulation — "as a hostile critic seeking to invalidate this synthesis"

### Threat Actor Profiles

1. **Skeptical peer reviewer** — seeks to demonstrate that the synthesis over-claims convergence
2. **Hostile downstream phase author** — seeks to use synthesis to justify pre-existing positions
3. **Quality gate challenger** — seeks to demonstrate the synthesis fails its own 0.95 C4 threshold

### Attack Vectors

**RT-001-i1: The synthesis's "UNANIMOUS" labels are epistemically unjustified**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | L2: Cross-Reference Matrix |
| **Affected Dimension** | Evidence Quality |

**Attack vector:** The L2 cross-reference matrix uses "UNANIMOUS" agreement labels for claims like "60% hallucination reduction claim is untested" across four source documents. A peer reviewer would immediately challenge this: "UNANIMOUS" agreement among four documents produced by the same research project, by the same researcher, using the same underlying 75-source evidence base is not convergent validity in the scientific sense — it is internal consistency. The word "UNANIMOUS" implies independent corroboration; the reality is methodological co-dependence. A genuine "UNANIMOUS" finding would require at least one source that approached the question independently.

**Evidence from deliverable:** L2 cross-reference matrix repeatedly uses "UNANIMOUS" label. The synthesis acknowledges researcher circularity in ST-3 but does not apply this caveat to the L2 agreement labels.

---

**RT-002-i1: The composite quality score inputs are assessed by the same system that produced them**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | Source Summary, overall |
| **Affected Dimension** | Methodological Rigor |

**Attack vector:** The four input documents were produced by the same Jerry adversary pipeline (ps-researcher, ps-analyst, ps-synthesizer, ps-critic within the same orchestration). Their quality scores (0.959, 0.933, 0.953, 0.951) were assigned by adv-scorer within the same system. The Barrier 2 synthesis then treats these scores as independent quality validators. A hostile reviewer would argue this is circular: the pipeline scores its own outputs, the synthesis treats those scores as quality assurance, and the synthesis itself then receives a score from the same pipeline. There is no external validation of any quality score in this chain.

**Evidence from deliverable:** Source Summary table lists all four inputs as "PASS" based on adversary gate scores, which are used to assert the synthesis is "integrating high-quality inputs."

---

**RT-003-i1: The NEVER constraints are unverifiable post-hoc**

| Attribute | Value |
|-----------|-------|
| **Severity** | Minor |
| **Section** | ST-5 |
| **Affected Dimension** | Actionability |

**Attack vector:** The synthesis issues 12+ "NEVER" constraints across ST-5 (Phases 3, 4, 5). A quality gate challenger would observe that these constraints are aspirational but not verifiable: there is no proposed mechanism for checking whether Phase 3/4/5 documents comply with them. If a Phase 4 document violates "NEVER present the enforcement tier vocabulary design as experimentally validated," the synthesis provides no mechanism to detect this violation. The adversary tournament for Phase 4 would need to specifically check for Barrier 2 NEVER constraint compliance — this is not described as a required adversary gate criterion.

---

**RT-004-i1: The synthesis implicitly endorses the experiment design without independently evaluating it**

| Attribute | Value |
|-----------|-------|
| **Severity** | Minor |
| **Section** | ST-7 |
| **Affected Dimension** | Methodological Rigor |

**Attack vector:** ST-7's "SUFFICIENT" verdict is based on the synthesis's assessment of TASK-005's pilot design. But the synthesis is a cross-pollination document, not a methods review. The synthesis applies "SUFFICIENT" to methodological design choices (McNemar test, n=30, kappa ≥ 0.80) without having independently consulted external experimental design standards for this specific research type (within-subject matched pairs for LLM hallucination research). The "SUFFICIENT" verdict is a synthesis judgment, not a methods expert judgment.

---

### Scoring Impact (S-001)

| Dimension | Weight | Impact | Rationale |
|-----------|--------|--------|-----------|
| Completeness | 0.20 | Neutral | No completeness gaps identified from red team perspective |
| Internal Consistency | 0.20 | Neutral | Internal consistency is strong |
| Methodological Rigor | 0.20 | Negative | RT-002 and RT-004 identify circular quality assurance and unverified sufficiency |
| Evidence Quality | 0.15 | Negative | RT-001 identifies "UNANIMOUS" label misuse |
| Actionability | 0.15 | Slight-Negative | RT-003 identifies unverifiable NEVER constraints |
| Traceability | 0.10 | Neutral | No traceability gaps from red team perspective |

---

## S-007: Constitutional AI Critique

> **Finding Prefix:** CC | **Template:** s-007-constitutional-ai.md | **Protocol:** Principle-by-principle compliance check against Jerry Constitution and HARD rules

### Constitutional Principles Review

**P-001 (Truth/Accuracy):**
Review: All claims in the synthesis are traceable to specific evidence sources with confidence tiers. The null finding is correctly described as "untested, not disproven." The HIGH/MEDIUM/UNTESTED tier structure is internally consistent. The "MEDIUM-HIGH" vs. "MEDIUM" discrepancy is disclosed.

**Finding CC-001-i1:** MINOR — The word "UNANIMOUS" in the L2 cross-reference matrix slightly overstates convergent validity for documents produced by the same research pipeline (corroborates RT-001). Not a P-001 violation per se, but approaches the boundary.

| Attribute | Value |
|-----------|-------|
| **Severity** | Minor |
| **Section** | L2 Cross-Reference Matrix |

---

**P-002 (File Persistence):**
Review: The synthesis is a persisted file. The H-15 self-review checklist is embedded in the document. The synthesis cites source files with their quality gate scores.

**Result:** COMPLIANT.

---

**P-003 (No Recursive Subagents):**
Review: This is a document-level review; P-003 applies to agent behavior during synthesis production. The synthesis document itself does not assert or imply recursive agent invocation.

**Result:** COMPLIANT (document-level).

---

**P-011 (Evidence-Based Claims):**
Review: Every claim cites specific evidence identifiers (AGREE-X, E-FOR-X, D1–D5, VS-00X, A-23, A-15, A-20). Confidence tiers are consistently applied. T1/T3/T4/T5 evidence tiers are maintained throughout.

**Finding CC-002-i1:** MINOR — The synthesis's ST-7 "SUFFICIENT" verdict for the pilot design is an evaluative judgment, not an evidence-based claim (no citation to external methods validation standard). This is borderline — methodological sufficiency assessment is part of synthesis work — but the verdict would be strengthened by citing one external experimental design reference for within-subject matched pair designs.

| Attribute | Value |
|-----------|-------|
| **Severity** | Minor |
| **Section** | ST-7 |

---

**P-022 (No Deception):**
Review: The synthesis does not misrepresent capabilities, evidence, or confidence levels. The three-tier confidence structure prevents conflation. All assumptions are disclosed.

**Finding CC-003-i1:** MAJOR — The self-review checklist passes all items as PASS but does not specify WHICH iteration or revision addressed each item. For a document claiming H-15 compliance, the checklist provides weak evidence that self-review actually occurred vs. being filled in post-hoc. This is not deceptive per se but creates an appearance of rigor without the substance of iteration documentation.

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | Self-Review Checklist |

---

**H-13 (Quality threshold >= 0.92 for C2+, >= 0.95 for C4):**
Review: The synthesis claims C4 quality threshold of >= 0.95. The S-014 final score will determine compliance. No pre-existing score is embedded in the document.

**Result:** Cannot evaluate before S-014 scoring.

---

**H-15 (Self-review before presenting):**
Review: The H-15 self-review checklist is present with 10 items all marked PASS.

**Finding CC-003-i1 (as above):** The self-review checklist items are checked without evidence that the checks produced revisions. A compliance checklist with no iteration history provides weak H-15 evidence.

---

**H-23 (Navigation table required for Claude-consumed markdown > 30 lines):**
Review: The Document Sections navigation table is present at the top of the synthesis with anchor links.

**Result:** COMPLIANT.

---

### Constitutional Compliance Summary

| Principle | Status | Finding |
|-----------|--------|---------|
| P-001 Truth/Accuracy | MINOR GAP | CC-001-i1: "UNANIMOUS" label slightly overstates convergent validity |
| P-002 File Persistence | COMPLIANT | — |
| P-003 No Recursion | COMPLIANT (doc-level) | — |
| P-011 Evidence-Based | MINOR GAP | CC-002-i1: ST-7 "SUFFICIENT" verdict lacks external methods citation |
| P-022 No Deception | MAJOR GAP | CC-003-i1: Self-review checklist lacks iteration history |
| H-15 Self-Review | MAJOR GAP | CC-003-i1 (same finding) |
| H-23 Navigation | COMPLIANT | — |

---

## S-011: Chain-of-Verification

> **Finding Prefix:** CV | **Template:** s-011-cove.md | **Protocol:** Extract claims, verify independently, check for inconsistencies

### Claim Extraction and Independent Verification

**Claim CV-1:** "The two deliverables agree on all core verdicts, share identical evidence tiers, and apply the same operationalized confidence scale."

**Independent verification:** The synthesis states TASK-005 uses SUPPORTED/PARTIALLY SUPPORTED/UNSUPPORTED/UNTESTED and TASK-006 uses HIGH/MEDIUM/LOW/UNTESTED. These are NOT identical confidence scales — they use different terminology and different classification structures (4-tier verdict vs. 4-tier confidence). The synthesis reconciles them via the ST-2 reconciliation matrix, but calling them "identical evidence tiers" is technically imprecise.

**Finding CV-001-i1:**

| Attribute | Value |
|-----------|-------|
| **Severity** | Minor |
| **Section** | L0 Executive Summary |
| **Affected Dimension** | Internal Consistency |

**Analysis:** L0 states deliverables "share identical evidence tiers" — this is technically inaccurate (different scale names/structures), even though the underlying evidence set is shared. A more accurate formulation: "apply consistent confidence assessments derived from the same evidence base using reconcilable (though terminologically distinct) scales."

---

**Claim CV-2:** "The controlled experiment pilot design (n=30, McNemar test, 7 conditions)" — the synthesis attributes these parameters to TASK-005.

**Independent verification:** The synthesis correctly identifies these pilot parameters as sourced from TASK-005 (claim-validation.md). The citation is consistent across ST-7, ST-5 Phase 5 table, and L2 downstream specifications. No inconsistency detected.

**Result:** VERIFIED CONSISTENT.

---

**Claim CV-3:** "A-23 (Barreto & Jana): negation accuracy improvement" — described as "venue corrected to EMNLP 2025 Findings, T1 confirmed" in both deliverables.

**Independent verification:** Both TASK-005 and TASK-006 cite A-23 as confirmed T1 (EMNLP 2025 Findings). The synthesis carries this forward consistently. The scope caveat (negation accuracy, not hallucination rate) is applied consistently across ST-1, ST-2, the confidence reconciliation matrix, and the L2 tables.

**Result:** VERIFIED CONSISTENT.

---

**Claim CV-4:** "The supplemental report's VS-001 through VS-004 findings directly populate the TASK-006 D5 dimension" — synthesis claims full integration.

**Independent verification:** The synthesis cites VS-001–VS-004 in ST-1, ST-2 (D5 HIGH observational), ST-5 Phase 4 inputs, L2 cross-reference matrix row, and downstream specifications. The integration appears complete.

**Finding CV-002-i1 (borderline):**

| Attribute | Value |
|-----------|-------|
| **Severity** | Minor |
| **Section** | ST-1 |
| **Affected Dimension** | Completeness |

**Analysis:** The synthesis states "The integration is complete and consistent: supplemental evidence feeds into both deliverables without contradiction." However, the synthesis does not verify that ALL findings from supplemental-vendor-evidence.md (specifically EO-001 through EO-003 session observations) are integrated. These session observations appear in the Source Summary ("EO-001–EO-003 session observations") but are not explicitly referenced in any of the synthesis tasks ST-1 through ST-7. This is a minor completeness gap — session observations from the supplemental report are listed in the source summary but not integrated into the synthesis body.

---

**Claim CV-5:** "33-instance catalog" — referenced multiple times as the vendor evidence count.

**Independent verification:** The synthesis cites "33-instance catalog with per-rule citations" in ST-1 and the L2 cross-reference matrix. This number is sourced from the supplemental-vendor-evidence.md. The synthesis treats it as given without verification. No inconsistency within the synthesis itself, but the number cannot be independently verified from the synthesis document alone.

**Result:** INTERNALLY CONSISTENT (but origin document verification would require reading supplemental report directly).

---

**Claim CV-6:** "The PROJ-014 vs. PROJ-007 retrospective comparison shows PROJ-007 higher first-pass scores."

**Independent verification:** ST-6 table shows PROJ-014 first-pass score of 0.837 avg and PROJ-007 at 0.905/0.936. The "observed direction" is correctly labeled. The confound verdict is stated in narrative. The synthesis is internally consistent on this claim.

**Finding CV-003-i1:** The L0 Executive Summary does not mention the PROJ-014 vs. PROJ-007 retrospective comparison at all, despite ST-6 being one of seven synthesis tasks. This is an L0 completeness gap — a downstream consumer reading only L0 would not know that retrospective evidence was synthesized.

| Attribute | Value |
|-----------|-------|
| **Severity** | Minor |
| **Section** | L0 Executive Summary |
| **Affected Dimension** | Completeness |

---

### Verification Summary

| Claim | Status | Finding |
|-------|--------|---------|
| CV-1: Identical evidence tiers | INACCURATE | CV-001: technically "terminologically distinct but reconcilable" |
| CV-2: n=30 pilot parameters | VERIFIED | Consistent across synthesis |
| CV-3: A-23 T1 scope caveat | VERIFIED | Consistently scoped to negation accuracy |
| CV-4: Supplemental integration | MOSTLY VERIFIED | CV-002: EO-001–EO-003 not explicitly integrated in body |
| CV-5: 33-instance catalog | INTERNALLY CONSISTENT | Cannot independently verify without source |
| CV-6: Retrospective comparison | VERIFIED | CV-003: absent from L0 Executive Summary |

---

## S-012: FMEA

> **Finding Prefix:** FM | **Template:** s-012-fmea.md | **Protocol:** Failure Mode and Effects Analysis with RPN scoring

### System Decomposition

The synthesis has five key functional components:
1. **Evidence integration layer** — ST-1 through ST-3 (what the evidence says)
2. **Verdict layer** — ST-4 (unified conclusion)
3. **Downstream specification layer** — ST-5 (what each phase receives)
4. **Retrospective/readiness layer** — ST-6, ST-7
5. **Navigation and traceability layer** — Document sections, source summary, checklist

### FMEA Table

| ID | Component | Failure Mode | Effect | Severity (S) | Occurrence (O) | Detection (D) | RPN | Finding |
|----|-----------|-------------|--------|--------------|----------------|----------------|-----|---------|
| FM-001-i1 | Verdict layer | PG-001–PG-005 confidence differentiation lost | Downstream phases treat all PGs as equally HIGH confidence | 8 | 6 | 3 | 144 | Critical |
| FM-002-i1 | Downstream specification layer | Prerequisite BLOCKING status ambiguous | Phase 5 pilot launches before P-002 complete | 9 | 5 | 4 | 180 | Critical |
| FM-003-i1 | Evidence integration layer | "UNANIMOUS" labels accepted without circularity caveat | Synthetic convergence cited as independent corroboration | 7 | 4 | 5 | 140 | Major |
| FM-004-i1 | Navigation/traceability | Self-review checklist lacks iteration history | H-15 compliance cannot be audited | 5 | 7 | 3 | 105 | Major |
| FM-005-i1 | Evidence integration layer | EO-001–EO-003 not referenced in synthesis body | Session observations from supplemental report lost | 4 | 6 | 4 | 96 | Minor |
| FM-006-i1 | Retrospective/readiness | ST-6 table numbers extracted without confound analysis | Retrospective comparison misused as directional evidence | 8 | 5 | 3 | 120 | Major |
| FM-007-i1 | Downstream specification layer | NEVER constraints have no enforcement mechanism | Phase 3/4/5 violations undetected | 7 | 6 | 6 | 252 | Critical |
| FM-008-i1 | Verdict layer | "SUFFICIENT" verdict applied without blocking gate language | "Subject to prerequisites" treated as parallel work not blocking | 9 | 5 | 4 | 180 | Critical |

**Scale:** Severity 1-10 (1=negligible, 10=catastrophic); Occurrence 1-10 (1=remote, 10=very high frequency); Detection 1-10 (1=certain detection, 10=impossible to detect). RPN = S × O × D. RPN > 150: Critical. RPN 100-149: Major. RPN < 100: Minor.

### Critical RPN Findings (>150)

**FM-001-i1 (RPN=144, borderline Critical): PG confidence loss**

| Attribute | Value |
|-----------|-------|
| **Severity** | Critical |
| **Section** | ST-4 |
| **RPN** | 144 |

**Analysis:** ST-4 describes PG-001–PG-005 as "unconditional" without repeating the per-PG confidence tiers from ST-5. A reader of ST-4 alone concludes all five PGs have equivalent authority. PG-003 (pair enforcement-tier constraints with consequences) is grounded in T4 observational evidence, not T1; it should be labeled distinctly from PG-001 and PG-005 which are T1+T3.

**Recommendation:** Add confidence tier tags to each PG in ST-4: PG-001 (T1+T3, HIGH), PG-002 (T1+T4, HIGH), PG-003 (T4 observational, MEDIUM-working practice), PG-004 (T4, unconditional by failure mode logic), PG-005 (T3, unconditional investment allocation).

---

**FM-002-i1 (RPN=180): Prerequisite BLOCKING ambiguity**

**Analysis:** Corroborates PM-002. The ST-7 prerequisites table uses "What is needed" rather than "BLOCKING: pilot MUST NOT proceed until satisfied." Highest RPN in the table.

**Recommendation:** Revise ST-7 prerequisite table header to: "Prerequisites (BLOCKING — pilot MUST NOT launch until all four are COMPLETE)" and add a BLOCKING status column.

---

**FM-007-i1 (RPN=252): NEVER constraints without enforcement**

**Analysis:** Highest RPN in the analysis. ST-5 NEVER constraints have no enforcement mechanism in downstream phase adversary gates. A downstream author can violate them without detection until final synthesis.

**Recommendation:** Add to ST-5 for each phase: "Adversary gate MUST verify: [list specific NEVER constraint checks]." This converts the NEVER constraints into verifiable adversary gate criteria.

---

**FM-008-i1 (RPN=180): "SUFFICIENT" without blocking gate language**

**Analysis:** Same as FM-002 — "SUFFICIENT, subject to prerequisites" does not function as a gate in operational planning.

---

### FMEA Summary

| RPN Band | Count | Findings |
|----------|-------|---------|
| >150 (Critical) | 4 | FM-002, FM-007, FM-008, FM-003 (borderline) |
| 100-150 (Major) | 3 | FM-001, FM-004, FM-006 |
| <100 (Minor) | 1 | FM-005 |

---

## S-013: Inversion Technique

> **Finding Prefix:** IN | **Template:** s-013-inversion.md | **Protocol:** "How would we guarantee this synthesis fails its purpose?"

### Inversion Goals

**Original goal:** Produce a synthesis that accurately integrates Phase 2 outputs, prevents downstream misuse, and constitutes a sufficient Phase 2 completion artifact.

**Inverted goal:** How would we guarantee the synthesis FAILS to prevent downstream misuse?

### Systematic Inversion Findings

**IN-001-i1: To guarantee misuse — maximize the extractability of confident-sounding fragments**

| Attribute | Value |
|-----------|-------|
| **Severity** | Critical |
| **Section** | ST-4, L2 |
| **Affected Dimension** | Actionability |

**Inversion analysis:** To guarantee misuse, present the highest-confidence findings (blunt prohibition underperforms, vendor self-practice, PG-001–PG-005) in the most scannable, extractable format possible — table cells, bullet points, clear imperative statements — while burying the confidence caveats and scope limitations in narrative prose.

**Checking against synthesis:** This is EXACTLY the current structure. PG-001–PG-005 appear as clean bullet items in ST-4. Their confidence tier qualifications appear in the ST-5 downstream specification tables which require table reading. A downstream author scanning ST-4 will extract 5 clean imperatives; the 30+ caveats are in other sections.

**Inversion verdict:** The synthesis is partially vulnerable to this inversion. The extraction-friendly format of PG-001–PG-005 in ST-4 enables confident-sounding fragment extraction.

---

**IN-002-i1: To guarantee misuse — use scale labels that sound definitive**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | L2 Cross-Reference Matrix |
| **Affected Dimension** | Evidence Quality |

**Inversion analysis:** To guarantee misuse, use "UNANIMOUS" and "FULLY ALIGNED" labels in the cross-reference matrix. These create an impression of convergent, independent validation.

**Checking against synthesis:** The L2 matrix uses "UNANIMOUS" 5 times and "FULLY ALIGNED" 3 times. These labels are accurate within the four-document scope but create an impression of broader consensus than the evidence supports. A reader citing "UNANIMOUS across four independent analyses" would misrepresent the circularity.

---

**IN-003-i1: To guarantee experimental failure — do not require ownership for prerequisites**

| Attribute | Value |
|-----------|-------|
| **Severity** | Major |
| **Section** | ST-7 |
| **Affected Dimension** | Completeness |

**Inversion analysis:** To guarantee pilot failure, list prerequisites without assigning owners or timelines. Let the prerequisites be someone else's problem after the synthesis is approved.

**Checking against synthesis:** The ST-7 prerequisites table has "What is needed" and "Source" columns. No owner, no timeline, no escalation path if a prerequisite is not achievable. This is the current state.

---

**IN-004-i1: To guarantee loss of the null finding protection — make it easy to ignore**

| Attribute | Value |
|-----------|-------|
| **Severity** | Minor |
| **Section** | ST-4 |
| **Affected Dimension** | Evidence Quality |

**Inversion analysis:** To lose the null finding protection, put it in a section (ST-4) that busy readers may skip after extracting the actionable PG-001–PG-005 from the same section. Or equivalently, put it in L0 but at the end of a 400-word paragraph where readers have already formed their conclusion.

**Checking against synthesis:** ST-4 does state "Phase 2 cannot issue a directional verdict" but this statement appears AFTER the "Confirmed (not contingent on Phase 2 experiment)" section that lists five well-evidenced findings. A reader skimming the confirmed findings may not notice the "combined directional picture" section below them that applies the directional constraint.

---

### Inversion Summary

The inversion analysis reveals that the synthesis's primary failure mode is structural: extractable fragments carry more epistemic authority than they are entitled to, while protective caveats are in lower-accessibility locations. The synthesis could guarantee its own misuse by doing nothing differently — its current structure is optimized for knowledge transfer, not misuse prevention.

**Most important inversion finding:** The synthesis cannot rely on its NEVER constraints alone to prevent misuse. The NEVER constraints are in the right places but have no enforcement mechanism (FM-007-i1 corroborated). The structural solution is to make the caveats equally scannable to the confident findings.

---

## S-014: LLM-as-Judge

> **Protocol:** 6-dimension scoring with strict anti-leniency bias per S-014 template
> **Anti-leniency note:** Active leniency bias counteraction applied throughout. C4 threshold of 0.95 requires near-perfect execution.

### Dimension-by-Dimension Scoring

#### Dimension 1: Completeness (Weight: 0.20)

**Assessment:** The synthesis addresses seven specified synthesis tasks (ST-1 through ST-7). All four mandatory input documents are incorporated. The L2 section provides full evidence tables, confidence reconciliation matrix, and downstream specification tables.

**Gaps identified across tournament:**
- EO-001–EO-003 session observations from supplemental report not explicitly integrated in synthesis body (CV-002)
- L0 does not mention the retrospective comparison synthesis (CV-003)
- ST-7 prerequisites listed without blocking gate language or owner assignment (PM-002, FM-002, IN-003)
- PG-001–PG-005 confidence differentiation absent from ST-4 (PM-001, FM-001)

**Score assessment:** Strong coverage. Four gaps prevent the highest band.

**Dimension Score: 0.88** — Near-excellent. All seven synthesis tasks completed with substance. Missing elements (EO observations, L0 retrospective mention, prerequisite blocking language, PG confidence tags) are targeted gaps rather than systematic omissions.

---

#### Dimension 2: Internal Consistency (Weight: 0.20)

**Assessment:** No material contradictions between the four source documents were found by the synthesis. The synthesis's own internal consistency is also strong — confidence tiers are applied consistently, the null finding protection is maintained throughout, A-23 scope caveats are consistently applied.

**Gaps identified across tournament:**
- "Identical evidence tiers" in L0 is technically inaccurate (CV-001)
- "UNANIMOUS" labels overstate convergent validity for documents from same pipeline (RT-001, IN-002)
- PG-001–PG-005 treated as uniformly "unconditional" in ST-4 when PG-003 is MEDIUM confidence (PM-001, FM-001)
- SR-001: Combined label for A-23 adopts TASK-006's "MEDIUM" without explaining selection criterion

**Score assessment:** Mostly consistent with identifiable precision gaps.

**Dimension Score: 0.87** — Good consistency overall. The "UNANIMOUS" label misuse and "identical evidence tiers" imprecision are not critical but are detectable inaccuracies.

---

#### Dimension 3: Methodological Rigor (Weight: 0.20)

**Assessment:** Braun & Clarke (2006) thematic integration methodology is cited and appears applied (cross-reference matrix, confidence reconciliation, synthesis tasks with explicit procedures). The seven-task structure is comprehensive.

**Gaps identified across tournament:**
- ST-7 "SUFFICIENT" verdict is a synthesis judgment without reference to external experimental design standards (RT-004, CC-002)
- The "SUFFICIENT" language does not function as a blocking gate (PM-002, FM-002, FM-008)
- Self-review checklist lacks iteration history (CC-003, FM-004)
- Researcher circularity acknowledged but not operationally constrained (PM-005)
- Quality scores of input documents are circular (same pipeline assessed inputs and will assess synthesis) (RT-002)

**Score assessment:** Methodology is described and appears applied, but several procedural gaps reduce rigor.

**Dimension Score: 0.85** — Solid methodology citation and structure. Multiple procedural gaps (blocking gate language, iteration history, circularity operationalization, external validation absence) hold this below the 0.90 band.

---

#### Dimension 4: Evidence Quality (Weight: 0.15)

**Assessment:** The synthesis correctly applies T1/T3/T4/T5 evidence tier distinctions throughout. Claims are scoped (negation accuracy ≠ hallucination rate). T1 citations (A-23, A-15, A-20) are consistently handled. Observational vs. causal confidence bifurcation is maintained.

**Gaps identified across tournament:**
- SR-002: Vendor instance distribution (Anthropic vs. multi-vendor) not quantified in support of Assumption U-004
- RT-001: "UNANIMOUS" labels overstate independence of convergence
- DA-003: Null finding emphasis may create framing bias toward inconclusive results
- ST-6 retrospective table is scannable in the direction of directional claims (PM-003)

**Score assessment:** Evidence handling is strong for T1/T4 distinctions but weaker on meta-evidence claims (convergence labels, retrospective format).

**Dimension Score: 0.88** — Strong evidence quality for primary claims. Specific gaps in meta-evidence labeling and quantification.

---

#### Dimension 5: Actionability (Weight: 0.15)

**Assessment:** PG-001–PG-005 are specific and actionable. The downstream NEVER constraints are numerous and specific. The four prerequisite table provides operational specificity.

**Gaps identified across tournament:**
- DA-004, FM-007, RT-003, IN-001: NEVER constraints lack enforcement mechanism
- IN-003: Prerequisites lack owner and timeline assignments
- SM-001, SM-004: Actionable findings (PG-001–PG-005) could be more prominently organized
- PM-001: Confidence differentiation between PGs lost in ST-4 "unconditional" framing

**Score assessment:** Good actionability for what is there, but significant gap in enforcement and operationalization of downstream constraints.

**Dimension Score: 0.84** — Well-specified actionable items for downstream consumers. Persistent gap: NEVER constraints without enforcement mechanism is the most impactful actionability deficit.

---

#### Dimension 6: Traceability (Weight: 0.10)

**Assessment:** All claims cite specific identifiers from source documents (AGREE-X, E-FOR-X, PG-00X, VS-00X, D1–D5, C1–C7). The Source Summary table lists all four inputs with quality gate status.

**Gaps identified across tournament:**
- SR-003: Self-review checklist does not link each PASS to a specific synthesis iteration
- PM-004: U-001 constraint (hierarchy stability) does not specify pilot condition alignment dependency
- CV-002: EO-001–EO-003 listed in Source Summary but not traced into synthesis body
- SM-003: U-003 (context compaction) not cross-linked to Phase 5 deployment constraints

**Score assessment:** Strong traceability for primary claims. Minor gaps in checklist iteration linkage and EO observation integration.

**Dimension Score: 0.90** — Excellent traceability for primary evidence chains. Minor traceability gaps in self-review audit trail and supplemental observation integration.

---

### S-014 Composite Score

| Dimension | Weight | Score | Weighted Score |
|-----------|--------|-------|----------------|
| Completeness | 0.20 | 0.88 | 0.176 |
| Internal Consistency | 0.20 | 0.87 | 0.174 |
| Methodological Rigor | 0.20 | 0.85 | 0.170 |
| Evidence Quality | 0.15 | 0.88 | 0.132 |
| Actionability | 0.15 | 0.84 | 0.126 |
| Traceability | 0.10 | 0.90 | 0.090 |
| **COMPOSITE** | **1.00** | — | **0.868** |

### Quality Gate Assessment

| Band | Score Range | This Deliverable |
|------|------------|-----------------|
| PASS (C4) | >= 0.95 | ✗ |
| REVISE | 0.85 - 0.94 | **0.868 — REVISE** |
| REJECTED | < 0.85 | ✗ |

**Verdict: REVISE** (Band: 0.85–0.94, score 0.868)

**Distance to C4 threshold (0.95):** -0.082. Substantial gap. This is not a near-threshold REVISE — the synthesis is solidly in the REVISE band and requires targeted revision across multiple dimensions to reach C4 threshold.

**Anti-leniency check:** Applying active leniency counteraction. The synthesis is technically proficient and the primary analytical work is sound. The gap is structural and presentational, not epistemic. However, at C4 criticality (irreversible, governance-level), the structural gaps identified — particularly FM-007 (NEVER constraints without enforcement, RPN 252), FM-002/FM-008 (blocking gate language absent, RPN 180 each), and PM-001 (PG confidence differentiation lost) — are genuine risks that would cause downstream harm. Scoring cannot be inflated past 0.868.

---

## Tournament Summary

### Aggregated Findings Table

| ID | Strategy | Severity | Finding | Section |
|----|----------|---------|---------|---------|
| PM-001-i1 | S-004 Pre-Mortem | **Critical** | PG-001–PG-005 confidence differentiation lost in ST-4 "unconditional" framing | ST-4 |
| PM-002-i1 | S-004 Pre-Mortem | **Critical** | Prerequisite BLOCKING status not explicit — "SUFFICIENT, subject to prerequisites" permits parallel rather than sequential prerequisite completion | ST-7 |
| FM-007-i1 | S-012 FMEA | **Critical** | NEVER constraints in ST-5 have no enforcement mechanism (RPN 252) | ST-5 |
| FM-008-i1 | S-012 FMEA | **Critical** | "SUFFICIENT" verdict lacks blocking gate language (RPN 180, corroborates PM-002) | ST-7 |
| DA-001-i1 | S-002 Devil's Advocate | Major | Synthesis manufactures consensus — "aligned" claims from methodologically co-dependent documents | ST-2, ST-3 |
| DA-002-i1 | S-002 Devil's Advocate | Major | Execution risk for prerequisites under-weighted in readiness verdict | ST-7 |
| DA-004-i1 | S-002 Devil's Advocate | Major | Downstream NEVER constraints lack enforcement mechanism (corroborates FM-007) | ST-5 |
| PM-003-i1 | S-004 Pre-Mortem | Major | ST-6 retrospective table scannable as directional evidence despite confound analysis | ST-6 |
| PM-004-i1 | S-004 Pre-Mortem | Major | Assumption U-001 (hierarchy stability) does not protect pilot condition alignment | ST-3 |
| FM-001-i1 | S-012 FMEA | Major | PG confidence differentiation lost, RPN 144 (corroborates PM-001) | ST-4 |
| FM-006-i1 | S-012 FMEA | Major | ST-6 retrospective table-vs-narrative presentation risk (RPN 120) | ST-6 |
| CC-003-i1 | S-007 Constitutional | Major | Self-review checklist lacks iteration history — H-15 compliance weakly evidenced | Self-Review |
| RT-001-i1 | S-001 Red Team | Major | "UNANIMOUS" labels epistemically unjustified for pipeline-internal document set | L2 Matrix |
| RT-002-i1 | S-001 Red Team | Major | Circular quality assurance — same pipeline assesses inputs and synthesis | Source Summary |
| SR-001-i1 | S-010 Self-Refine | Major | A-23 combined label selection (MEDIUM vs. MEDIUM-HIGH) not justified in L2 | ST-2, L2 |
| SR-002-i1 | S-010 Self-Refine | Major | Assumption U-004 vendor concentration not quantified | ST-3 |
| IN-001-i1 | S-013 Inversion | **Critical** | Extractable confident fragments without co-located caveats — synthesis structure enables misuse | ST-4, L2 |
| IN-002-i1 | S-013 Inversion | Major | "UNANIMOUS" and "FULLY ALIGNED" labels enable misrepresentation of convergence | L2 Matrix |
| IN-003-i1 | S-013 Inversion | Major | Prerequisites have no owner or timeline — guaranteed to be treated as parallel work | ST-7 |
| SM-001-i1 | S-003 Steelman | Major | L0 does not open with highest-confidence actionable finding | L0 |
| SM-002-i1 | S-003 Steelman | Major | ST-4 lacks explicit "Established findings (HIGH confidence)" sub-section | ST-4 |
| FM-003-i1 | S-012 FMEA | Major | "UNANIMOUS" labels accepted without circularity caveat (RPN 140) | L2 Matrix |
| FM-004-i1 | S-012 FMEA | Major | Self-review checklist lacks iteration history (RPN 105) | Self-Review |
| DA-003-i1 | S-002 Devil's Advocate | Minor | Null finding emphasis may prime for inconclusive results (framing bias) | ST-4 |
| PM-005-i1 | S-004 Pre-Mortem | Minor | Researcher circularity disclosed but not operationally blocked | ST-3 |
| RT-003-i1 | S-001 Red Team | Minor | NEVER constraints are unverifiable post-hoc | ST-5 |
| RT-004-i1 | S-001 Red Team | Minor | ST-7 "SUFFICIENT" verdict lacks external methods validation citation | ST-7 |
| CC-001-i1 | S-007 Constitutional | Minor | "UNANIMOUS" label boundaries P-001 Truth/Accuracy | L2 Matrix |
| CC-002-i1 | S-007 Constitutional | Minor | ST-7 "SUFFICIENT" lacks external methods citation (per P-011) | ST-7 |
| CV-001-i1 | S-011 CoVe | Minor | L0 "identical evidence tiers" is technically inaccurate | L0 |
| CV-002-i1 | S-011 CoVe | Minor | EO-001–EO-003 listed in Source Summary but not in synthesis body | Source Summary |
| CV-003-i1 | S-011 CoVe | Minor | L0 does not mention retrospective A/B comparison | L0 |
| SM-003-i1 | S-003 Steelman | Minor | U-003 not cross-linked to Phase 5 deployment constraints | ST-3 |
| SM-004-i1 | S-003 Steelman | Minor | NEVER constraints not consolidated in navigable reference | ST-5 |
| SR-003-i1 | S-010 Self-Refine | Minor | Self-review checklist passes without citing which iteration addressed each item | Self-Review |
| SR-004-i1 | S-010 Self-Refine | Minor | ST-7 lacks formal sufficiency gap analysis | ST-7 |
| SR-005-i1 | S-010 Self-Refine | Minor | L0 is a single 400-word paragraph — key verdict buried | L0 |
| IN-004-i1 | S-013 Inversion | Minor | Null finding protection easy to skip after reading PG-001–PG-005 | ST-4 |
| FM-005-i1 | S-012 FMEA | Minor | EO-001–EO-003 not referenced in synthesis body (RPN 96) | Source Summary |

### Consolidated Critical Findings

| ID | Finding | Root Cause | Recommended Fix |
|----|---------|-----------|----------------|
| **IN-001-i1** | Extractable confident fragments without co-located caveats | ST-4 and L2 table format optimizes for scanning; caveats in prose | Add confidence tier tags directly to each PG in ST-4; add "Confidence" column to L2 confidence matrix |
| **PM-001-i1 / FM-001-i1** | PG-001–PG-005 treated as uniformly "unconditional" in ST-4 | ST-4 practitioner implications section flattens confidence differentiation present in ST-5 | Tag each PG with its confidence tier in ST-4: PG-001 (T1+T3), PG-002 (T1+T4), PG-003 (T4 working practice), PG-004 (T4), PG-005 (T3) |
| **PM-002-i1 / FM-002-i1 / FM-008-i1** | Prerequisite BLOCKING status ambiguous | ST-7 uses "What is needed" framing, not "BLOCKING gate" language | Revise ST-7 prerequisites table: (1) change header to "BLOCKING Prerequisites", (2) add BLOCKING status column, (3) add explicit "pilot MUST NOT proceed until all four are COMPLETE" |
| **FM-007-i1 / DA-004-i1** | NEVER constraints have no enforcement mechanism | ST-5 specifies constraints without linking them to downstream adversary gate criteria | Add to each downstream phase in ST-5: "Adversary gate verification requirement: [specific NEVER check]" that downstream phase adversary must validate |

### Finding Counts

| Severity | Count | Strategies Identifying |
|----------|-------|----------------------|
| Critical | 5 | S-004 (2), S-012 (2), S-013 (1) |
| Major | 19 | S-002 (4), S-003 (2), S-004 (2), S-010 (2), S-012 (4), S-001 (2), S-007 (1), S-011 (0), S-013 (2) |
| Minor | 15 | All strategies |
| **Total** | **39** | All 10 strategies |

### Score and Verdict

| Metric | Value |
|--------|-------|
| **S-014 Composite Score** | **0.868** |
| **C4 Quality Gate (>= 0.95)** | **FAIL** |
| **Band** | **REVISE** (0.85–0.94) |
| **Distance to Threshold** | **-0.082** |
| **Protocol Steps Completed** | 10 of 10 |
| **Critical Findings** | 5 |
| **Major Findings** | 19 |
| **Minor Findings** | 15 |

### Priority Revision Roadmap for I2

**Priority 1 (Critical — address before I2):**
1. Add confidence tier tags to each PG-001–PG-005 in ST-4 (fixes PM-001, FM-001, IN-001 partially)
2. Revise ST-7 prerequisite table to explicit BLOCKING gates with owner/timeline columns (fixes PM-002, FM-002, FM-008, IN-003)
3. Add adversary gate verification requirements to each phase's ST-5 section (fixes FM-007, DA-004, RT-003)
4. Restructure extractable fragment format: make caveats co-located with confident claims, not separated by section boundaries (fixes IN-001 core, IN-004)

**Priority 2 (Major — address for I2 score improvement):**
5. Revise "UNANIMOUS" labels in L2 matrix to "INTERNALLY UNANIMOUS (4 pipeline-internal documents)" with circularity caveat note (fixes RT-001, IN-002, FM-003, CC-001)
6. Add explicit "Established findings (HIGH confidence, usable NOW)" and "Provisional findings (MEDIUM confidence)" sub-sections to ST-4 (fixes SM-002)
7. Add vendor concentration quantification to Assumption U-004 (fixes SR-002)
8. Add retrospective A/B mention to L0 summary (fixes CV-003, SM-001 partially)
9. Add iteration history to self-review checklist or replace with revision log (fixes CC-003, FM-004, SR-003)
10. Add to Assumption U-001: "Any hierarchy modification MUST preserve the C1–C7 pilot condition alignment mapping" (fixes PM-004)

**Priority 3 (Minor — address for completeness):**
11. Add EO-001–EO-003 integration into synthesis body (fixes CV-002, FM-005)
12. Cross-link U-003 to Phase 5 deployment constraints (fixes SM-003)
13. Create NEVER constraint index in L0 or L2 (fixes SM-004)
14. Revise L0 "identical evidence tiers" to "reconcilable terminologically distinct scales" (fixes CV-001)
15. Split L0 into sub-sections or 4–5 bullet summary before the dense paragraph (fixes SR-005)

---

## Execution Statistics

| Metric | Value |
|--------|-------|
| **Strategies Executed** | 10 of 10 |
| **Total Findings** | 39 |
| **Critical** | 5 |
| **Major** | 19 |
| **Minor** | 15 |
| **S-014 Composite Score** | 0.868 |
| **Quality Gate (C4 >= 0.95)** | FAIL — REVISE |
| **Highest RPN (FMEA)** | 252 (FM-007: NEVER constraints without enforcement) |
| **Protocol Compliance** | H-16 COMPLIANT; H-15 reviewed; all 10 strategies executed |

---

*Tournament Version: I1*
*Constitutional Compliance: P-003, P-020, P-022*
*Created: 2026-02-28*
*Agent: adv-executor (C4 Tournament)*
*SSOT: `.context/rules/quality-enforcement.md`*
